‘Miracle drug’ euphoria: Experts warn widespread use of weight loss medicine faces major hurdles
Two experts see major challenges facing the adoption of Novo Nordisk and Eli Lilly's obesity drugs. Source link
Read More
Weight management
Ozempic, Wegovy drug prescriptions hit 9 million, surge 300% in under three years
The data confirms the rise in demand for GLP-1s, which have fueled a frenzy among Americans and on Wall Street
Read More
Obesity drug maker Versanis to be bought by Eli Lilly for $1.9 billion
The deal is Eli Lilly's latest attempt to capitalize on the weight loss industry gold rush, which was sparked by
Read More
People should stop taking Ozempic, Wegovy obesity drugs before surgery, doctors group says
Patients taking diabetes and weight loss drugs during anesthesia may be at increased risk of serious complications like nausea and
Read More
As drugmakers race to develop the next big weight loss pill, Eli Lilly may have an edge
For now, Eli Lilly's orforglipron appears to be the top contender in the weight loss pill space due to its
Read More
Eli Lilly’s weight loss drugs trounce sky-high expectations, boosting the stock
The weight loss medication market is shaping up to be a duopoly of Eli Lilly and Novo Nordisk, analysts said.
Read More